Cargando…

Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful

Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Hina J., Keraliya, Abhishek R., Jagannathan, Jyothi P., Tirumani, Sree Harsha, Lele, Vikram R., DiPiro, Pamela J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Radiology 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240489/
https://www.ncbi.nlm.nih.gov/pubmed/28096718
http://dx.doi.org/10.3348/kjr.2017.18.1.54
Descripción
Sumario:Diffuse large B cell lymphoma (DLBCL) is the most common histological subtype of Non-Hodgkin's lymphoma. As treatments continues to evolve, so do imaging strategies, and positron emission tomography (PET) has emerged as the most important imaging tool to guide oncologists in the diagnosis, staging, response assessment, relapse/recurrence detection,and therapeutic decision making of DLBCL. Other imaging modalities including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and conventional radiography are also used in the evaluation of lymphoma. MRI is useful for nervous system and musculoskeletal system involvement and is emerging as a radiation free alternative to PET/CT. This article provides a comprehensive review of both the functional and morphological imaging modalities, available in the management of DLBCL.